Sinojobs JOY商城 酒店预订 开元机票预订 中国转运 sinojob
查看: 56|回复: 0

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory ...

发表于 6.4.2021 02:52:20 | 显示全部楼层 |阅读模式
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in December 2019, with subsequent worldwide spread. The first US cases were identified in January 2020.

To determine if SARS-CoV-2–reactive antibodies were present in sera prior to the first identified case in the United States on 19 January 2020, residual archived samples from 7389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020 from donors resident in 9 states (California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington, and Wisconsin) were tested at the Centers for Disease Control and Prevention for anti–SARS-CoV-2 antibodies. Specimens reactive by pan-immunoglobulin (pan-Ig) enzyme-linked immunosorbent assay (ELISA) against the full spike protein were tested by IgG and IgM ELISAs, microneutralization test, Ortho total Ig S1 ELISA, and receptor-binding domain/ACE2 blocking activity assay.

Of the 7389 samples, 106 were reactive by pan-Ig. Of these 106 specimens, 90 were available for further testing. Eighty-four of 90 had neutralizing activity, 1 had S1 binding activity, and 1 had receptor-binding domain/ACE2 blocking activity >50%, suggesting the presence of anti–SARS-CoV-2–reactive antibodies. Donations with reactivity occurred in all 9 states.

These findings suggest that SARS-CoV-2 may have been introduced into the United States prior to 19 January 2020.

您需要登录后才可以回帖 登录 | 立即注册



【站长推荐】 上一条 /2 下一条


站点统计| 举报| Archiver| 手机版| 小黑屋

Powered by Discuz! X3.2 © 2001-2014 Comsenz Inc.

GMT+1, 17.5.2021 01:34


() 开元网

快速回复 返回顶部 返回列表